1 |
김진호, 한태륜. 재활의학. 서울:군자출판사. 2006:501-24.
|
2 |
대한정형외과학회. 정형외과학, 서울:최신의학사. 2006:253-61.
|
3 |
이윤종. 골관절염의 치료. 대한내과학회지. 2004;67(5):564-7.
|
4 |
한성훈. 골관절염의 약물치료. Inje medical journal. 2002;23(4):159-66.
|
5 |
송영준, 하철원. 골관절염의 치료에서 COX-2 선택적 비스테로이드성 소염진통제의 이용. 대한슬관절학회지. 2009;21(2):84-92.
|
6 |
한방재활의학과학회. 한방재활의학. 서울:군자출판사. 2011:84-98.
|
7 |
孫思邈. 備急千金要方. 서울:大星出版社. 1984:155.
|
8 |
이경애, 신길조, 이원철. 小續命湯 추출물이 고지혈증, PC-12 세포독성 및 NO production에 미치는 영향. 韓方成人病學會誌. 1999;5(1):123-36.
|
9 |
이경애, 신길조, 이원철. 小續命湯 抽出物이 全腦虛血 및 局所腦虛血에 미치는 影響. 東國韓醫學研究所論文集. 1999;8(1):107-16.
|
10 |
조영철, 손낙원. 小續命湯이 中腦動脈 閉鎖에 의한 虛血性 腦損傷에 미치는 影響. 慶熙韓醫大論文集. 1998;21(1):41-54.
|
11 |
김영균, 권정남, 김경민, 조은희, 박시은. 小續命湯이 白鼠의 局所腦血流量과 혈압血壓에 미치는 影響. 대한한방내과학회지. 2000;21(5):851-7.
|
12 |
吳謙 等編. 醫宗金鑑. 北京:人民衛生出版社. 1982:1046.
|
13 |
Janusz MJ, Hookfin EB, Heitmeyer SA, Woessner JF, Freemont AJ, Hoyland JA, Brown KK, Hsieh LC, Almstead NG, De B, Natchus MG, Pikul S, Taiwo YO. Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors. Osteoarthritis and Cartilage. 2001;9:751-60.
DOI
ScienceOn
|
14 |
許浚. 東醫寶鑑. 서울:법인문화사. 1999:950-1.
|
15 |
Rudolphi K, Gerwin N, Verziji N, van der Kraan P, van den Berg W. Pralnacasan, an inhibitor of interleukin-1 converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthritis and Cartilage. 2003;11(10):738-46.
DOI
ScienceOn
|
16 |
黄度淵. 新增方藥合編. 서울:영림사. 2002:183, 386.
|
17 |
이상인 외. 한약임상응용. 서울:전통의학연구소. 1998:36-7, 42-3, 114-6, 158-60, 199-207, 267-9, 308-13, 322-7, 346, 360-2, 475-6.
|
18 |
심상도, 김호철, 이상인, 안덕균. 구척(구척)이 난소적출로 유발한 흰쥐의 골다공증에 미치는 영향. 慶熙韓醫大論文集. 1995;24:377-86.
|
19 |
이지영, 고성훈, 이용재, 이세연, 박호준, 신태용, 전훈. IFN- 와 LPS로 자극된 쥐의 복강 대식세포에서 구척 메탄올 추출물의 항염증 효과. 생약학회지. 2010;41(2):108-14.
|
20 |
임강현, 김호철. 구척이 흰쥐의 장골 길이성장에 미치는 영향. 대한본초학회지. 2001;16(2):49-55.
|
21 |
Combe R, Bramwell S, Field MJ. The monosodium iodoacetate model of osteoarthritis. Neurosci Lett. 2004;370(2-3):236-40.
DOI
ScienceOn
|
22 |
Guzman RE, Evans MG, Bove S, Morenko B, Kilgore K. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol. 2003;31(6):619-24.
DOI
|
23 |
Guingamp C, Gegout-Pottie P, Philippe L, Terlain B, Netter P, Gillet P, Mono-iodoacetate-induced experimental osteoarthritis: a doseresponse study of loss of mobility, morphology, and biochemistry. Arthritis Rheum. 1997Sep;40(9):1670-9.
DOI
ScienceOn
|
24 |
김용문, 정수현, 김순중, 서일복. 加味消炎湯이 monosodium iodoacetate로 유발된 흰쥐의 골관절염에 미치는 영향. 한방재활의학과학회지. 2000;18(1):15-32.
|
25 |
이승헌, 정수현, 김순중, 서일복. 秦艽.威靈仙.夏枯草 복합방이 monosodium iodoacetate로 유발된 흰쥐의 골관절염에 미치는 영향. 한방재활의학과학회지. 2008;18(1):75-94.
|
26 |
생화학교재편찬위원회. 생화학. 서울:정문각. 2003:357-63.
|
27 |
Shinomura T. Proteoglycan knock-out mice and osteoarthritis. Clin Calcium. 2004Jul;14(7):58-63.
|
28 |
Chevalier X, Mugnier B, Bouvenot G. Targeted anti-cytokine therapies for osteoarthritis. Bull Acad Natl Med. 2006Oct;190(7):1411-20.
|
29 |
Calich AL, Domiciano DS, Fuller R. Osteoarthritis: can anti-cytokine therapy play a role in treatment?. Clin Rheumatol. 2010May;29(5):451-5.
DOI
ScienceOn
|
30 |
Abbas AK, Lichtman AH. 세포분자면역학. 서울:범문사. 2004:243-88.
|
31 |
Hulejova H, Baresova V, Klezl Z, Polanska M, Adam M, Senolt L. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine. 2007;38(3):151-6.
DOI
ScienceOn
|
32 |
Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987;330(6149):662-4.
DOI
ScienceOn
|
33 |
Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment on rheumatoid arthritis. Lancet. 2007;370(9602):1861-74.
DOI
ScienceOn
|
34 |
Vilcek J, Lee TH. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem. 1991;266(12):7313-6.
|
35 |
LeGrand A, Fermor B, Fink C, Pisetsky DS, Weinberg JB, Vail TP, Guilak F. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci. Arthritis Rheum. 2001Sep;44(9):2078-83.
DOI
ScienceOn
|
36 |
Kuiper S, Joosten LA, Bendele AM, Edwards CK 3rd, Arntz OJ, Helsen MM, Van de Loo FA, Van den Berg WB. Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis. Cytokine. 1998;10(9):690-702.
DOI
ScienceOn
|
37 |
Needleman P, Isakson PC. The discovery and function of COX-2. J Rheumatol. 1997;24(Suppl 49):6-8.
|
38 |
Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs. 1996;52(Suppl 5):13-23.
DOI
|
39 |
Anggard E. Nitric oxide: mediator, murderer, and medicine. Lancet. 1994;9:1199-206.
|
40 |
Vuolteenaho K, Moilanen T, Knowles RG, Moilnen E. The role of nitric oxide in osteoarthritis. Scand J Rheumatol. 2007;36(4):247-58.
DOI
|
41 |
Abramson SB, Attur M, Amin AR, Clancy R. Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep. 2001;3(6):535-41.
DOI
ScienceOn
|
42 |
Skiles JW, Gonnella NC, Jeng AY. The design, structure, and therapeutic application of matrix metalloproteinase inhibitors. Curr Med Chem. 2001;8:425-74.
DOI
ScienceOn
|
43 |
Yamamoto S, Shimizu K, Shimizu K, Suzuki K, Nakagawa Y, Yamamuro T. Calcium-dependent cysteine proteinase in human arthritic synovial joints. Arthritis Rheum. 1992;35(11):1309-17.
DOI
|
44 |
Blom AB, van Lemt PL, Librigts S, Holthuysen AE, van der Kraan PM, van Rooijen N, van den Berg WB. Crucial role of macrophages in matrix Metalloproteinases-mediated cartilage destruction osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum. 2007;56(1):147-57.
DOI
ScienceOn
|
45 |
Fujhmori Y, Shimizu K, Suzuki K, Nakagawa Y, Yamamoto S, Yamomuro T. Immunohistochemical demonstration of calcium-dependent cysteine proteinase(calpain) in collagen-induced arthritis in mice. Z Rheumatol. 1994Mar-Apr;53(2):72-5.
|